Roivant Sciences Ltd. — Director's Dealing 2023

Apr 25, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2023-04-20

Reporting Person: Fitzgerald Meghan (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-20	Stock Option (Right to Buy)	$8.8	A	118578	Acquired	2033-04-19	Common Shares (118578)	Direct

Footnotes

F1: Award of stock options to purchase Common Shares with a vesting commencement date of March 13, 2023. These options vest and become exercisable (i) 1/3 on the first anniversary of the vesting commencement date and (ii) in twenty-four (24) successive equal monthly installments measured from the first anniversary of the vesting commencement date, subject to the reporting person's continuous service through the applicable vesting date.